Can You Reduce Diabetes Medication Safely? Exercise, Kidney Health and Type 2 Remission

Is it wrong to hope for less medicine?

Wanting less medicine is not wrong. The aim is to control the disease and limit complications with a plan that fits the person, not to minimize the tablet count while ignoring the blood tests.

Some people with type 2 diabetes improve with food, movement, and weight, enough that a clinician may reduce medicine. Some meet remission criteria. Stopping is not possible for every person.

Type 1 diabetes has absent or near-absent beta-cell function. The 2026 standards treat most adults with insulin, so a type 2 remission goal cannot stand in for type 1. The original post did not confirm the type, so a type 2 stopping plan cannot be applied to that person automatically.

Still needing medicine is not a failure of self-care.

What 201 in the morning and 117 at noon can say

A reading of 201 mg/dL at 06:24, if it was truly before food, is above the premeal range of 80–130 mg/dL used for many nonpregnant adults. That goal is individualized and is read with HbA1c. The 117 mg/dL at 11:42 is another time point. It does not erase the morning value.

Two readings do not show how long the person had fasted, what was eaten, how they slept, or whether stress or illness was present. They also do not diagnose an early-morning glucose pattern for the person who posted. Fatigue plus about a year off diabetes medicine is a reason to book a clinician promptly.

The page on a finger-stick glucose of 516 mg/dL is a different level from 201. The page on a post-meal glucose of 110–120 answers a diagnostic question, not medication reduction.

Do diabetes medicines damage the liver or the kidney?

Diabetes medicines do not affect the kidney in the same way, and they do not all damage the liver. Leaving glucose high for a long time because of fear of medicine can raise the risk to kidneys, eyes, nerves, and blood vessels.

For adults with type 2 diabetes and chronic kidney disease, section 11 recommends an SGLT2 inhibitor with demonstrated benefit to slow kidney disease and reduce cardiovascular events, started at an eGFR of at least 20 mL/min/1.73 m² and continued until kidney failure. It also recommends a GLP-1 receptor agonist with demonstrated benefit in that population. Those benefits are not identical for every product in the class, and they are not a reason to start a named medicine from a social-media post.

Section 9 also includes medicines with demonstrated cardiovascular benefit for adults with type 2 diabetes and atherosclerotic disease or high risk, and an SGLT2 inhibitor when heart failure is present, irrespective of A1C alone. Using less medicine must not trade away heart, kidney, or vascular protection.

Metformin and eGFR

Section 11 notes that dosing may need modification when eGFR is below 60. Metformin is not started when eGFR is below 45. If someone is already taking it and eGFR falls below 45, the benefits and risks of continuing are reassessed. That is not an instruction that every person must stop at once. Metformin is contraindicated when eGFR is below 30. Any dose change belongs to the care team and the product criteria, not to a self-made schedule.

During illness when a person cannot keep eating, or when acute kidney injury is a concern, the care team may hold metformin or an SGLT2 inhibitor for a time under that person’s plan. Holding a medicine in that setting is not a home decision to stop. People taking an SGLT2 inhibitor should avoid a ketogenic eating pattern because ketoacidosis has been reported.

Why long-standing high glucose involves the kidney

Chronic kidney disease is diagnosed by persistently high urine albumin, an eGFR below 60, or other kidney damage. It occurs in about 20–40% of people with diabetes. Type 2 diabetes may already show signs at diagnosis. Glucose and blood pressure control are the proven primary prevention steps, but albumin leak or a falling eGFR is then treated by stage. That is different from blaming every medicine.

Section 11 asks for a random urine albumin-to-creatinine ratio and an eGFR at least yearly in every person with type 2 diabetes, whether or not medicine is used, and in type 1 diabetes after at least 5 years. When kidney disease is already present, the interval is 1–4 times a year depending on stage.

Why HbA1c is needed

HbA1c reflects average glucose over about 2–3 months and is linked with complications. The standards assess glycemic status at least twice a year, and more often, such as every 3 months, when goals are missed, treatment has just changed, glucose swings are frequent, or health has changed. A finger-stick reading describes that moment. It does not replace HbA1c.

Some red-cell conditions, kidney failure, and pregnancy make HbA1c hard to read. The clinician then chooses another way to follow glucose.

Four terms that are not the same

A 4-week walking program as support

Section 5 counsels most adults to do at least 150 minutes a week of moderate- to vigorous-intensity aerobic activity, spread over at least 3 days, with no more than 2 days in a row without activity. Bouts should last at least 10 minutes, and resistance exercise is 2–3 sessions a week on nonconsecutive days. This table is a ramp for someone who can walk safely, has none of the emergency symptoms, and has no open foot wound.

Light strength examples are sit-to-stand from a chair, heel raises, and a resistance band, when feet, balance, heart disease, and other complications allow. An open foot wound means no weight-bearing walk.

People using insulin or an insulin secretagogue can develop low glucose if the dose or food is not matched to the activity. The page on a morning glucose of 41 mg/dL is a different situation, and it shows why activity raises that risk for people on those medicines. Very high glucose with illness, or suspected ketoacidosis, is not a reason to exercise in order to force the number down.

Walking after meals

Starting with 10 minutes after a meal fits the guideline that an activity bout last at least 10 minutes. The weekly total still needs to move toward 150 minutes when the person is ready. Prolonged sitting should be interrupted at least every 30 minutes. Someone below the guideline starts from what they already do, such as walking, housework, or gardening, rather than from high intensity.

Strength training

Resistance work supports glucose, strength, and muscle, and higher relative muscle mass is linked with better insulin sensitivity. Two or three sessions a week on nonconsecutive days are the standard. Any intensity can help strength and daily function. If a foot complication or balance problem is present, choose movements that do not load an open wound.

Carbohydrate portions without cutting out all starch

There is no single calorie split among carbohydrate, protein, and fat for every person with diabetes. A common plate is half nonstarchy vegetables, one quarter protein, and one quarter carbohydrate. Rice can stay on the plate. Sugar-sweetened drinks, sweets, and refined starch are the parts to limit. The standards emphasize vegetables, whole fruit, legumes, intact grains, and less red and processed meat.

A large carbohydrate cut can lower HbA1c in the short term. This page does not prescribe a ketogenic pattern or a strict fast for someone whose medicines are unknown. People taking an SGLT2 inhibitor should avoid a very-low-carbohydrate pattern because of ketoacidosis risk. People on fixed insulin doses need a steadier carbohydrate pattern to limit hypoglycemia.

Weight loss when weight is high

When weight is high, sections 5 and 8 support a plan of nutrition, physical activity, and behavioral support aimed at least 5–7% loss from baseline. That range can improve glucose and intermediate cardiovascular risk factors. Intake still has to be adequate, with follow-up. It is not a fast that adds exhaustion to the fatigue already present.

Sleep and morning glucose

The standards screen sleep health in people with diabetes and counsel sleep-promoting routines. A high morning reading can follow the previous evening’s food, the time since the last meal, sleep, stress, illness, or missed medicine. The two numbers in the post cannot separate those causes, so this page does not label an early-morning pattern for that person.

Can type 2 diabetes reach remission?

The 2021 consensus uses remission because glucose can return to the diabetes range. The usual criterion is HbA1c below 6.5% that persists for at least 3 months after glucose-lowering pharmacotherapy has stopped. Testing to document remission is done no sooner than 3 months after the intervention and after withdrawal of that medicine. Later testing is at least yearly, together with the usual complication checks.

One or two normal finger-stick readings do not count. A dose reduction does not count. Do not stop medicine to see whether the criterion is met. When HbA1c is unreliable, the consensus allows a fasting plasma glucose below 126 mg/dL or a continuous-monitor estimate below 6.5% under its stated conditions. A single home reading is not that alternate test.

When a clinician may reduce medicine

A shared decision uses HbA1c, finger-stick or monitor trends, hypoglycemia, heart disease, kidney disease, age, treatment burden, and the drug class. Section 6 supports deintensifying medicines that cause hypoglycemia when risk is high, or when harms outweigh benefits, inside individualized goals. That is not permission for someone whose glucose is still high after a year off medicine to cut more on their own.

If medicine is still needed, what is weighed

Section 9 chooses medicines by whether they can meet the glucose goal, effects on heart, kidney, and weight, hypoglycemia risk, cost, adverse effects, and the person’s preferences. An organ-protective medicine can still have a reason in someone who has the indication, even when the glucose goal is close. Continuing it is prevention, not a failure.

Kidney, heart, eye, and foot checks when indicated

Remission or a smaller medicine list still needs HbA1c and complication follow-up. Kidneys use eGFR and urine albumin as in section 11. Eyes and feet sit in section 12 of the same year’s standards. The page on blurred vision in diabetes answers a different question, and it shows that walking does not replace eye care.

The liver is not damaged by every diabetes medicine. Some agents are considered in selected fatty-liver disease under section 9 when there is an indication. Choice still depends on organ function. It is not a self-start.

Prepare information for a visit about adjusting medicine

1. The diabetes type, if known, and why medicine was stopped.
2. The generic name of every previous medicine. Do not guess from tablet color.
3. The latest HbA1c and the date.
4. A glucose log with times, such as 201 in the morning and 117 at noon, and whether food came first.
5. Fatigue, thirst, urination, and weight.
6. Ask about eGFR and urine albumin. Do not stop more medicine before the visit.

Questions readers ask

How this page separates the mechanisms

Asst. Prof. Dr. Norawit Raatpiboon separates three layers. Muscle used in walking and resistance work can help the body use glucose, and that effect is judged with HbA1c and follow-up, not with one noon reading. Kidney damage from long-standing high glucose, through small vessels and albumin leak, is different from a dose limit when the kidney clears less metformin. Some medicines affect kidney and heart outcomes beyond glucose lowering, and only the products with evidence, in people who have the indication.

Medical disclaimer

This is education based on documents opened while the page was prepared. It does not read the visitor’s blood tests and does not replace the treating clinician. Do not start, stop, or reduce a diabetes medicine on your own to test remission or to exercise. If a symptom in the emergency box is present, contact emergency services first.